NIDAN — Nidan Laboratories and Healthcare Cashflow Statement
0.000.00%
- IN₹189.04m
- IN₹280.73m
- IN₹255.42m
Annual cashflow statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 45.2 | 48.1 | -23.7 | 27.6 | 24.4 |
| Depreciation | |||||
| Non-Cash Items | 19 | 19.5 | 63.3 | -1.8 | 0.114 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.3 | 40.3 | -13 | -27.1 | -26.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 78.3 | 139 | 55.2 | 22.8 | 16.7 |
| Capital Expenditures | -70.7 | -6.68 | -7.36 | -9.4 | -4.77 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -287 | -23.2 | -98.7 | 7.21 | 5.38 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -357 | -29.9 | -106 | -2.19 | 0.612 |
| Financing Cash Flow Items | -24.4 | -22.2 | -19.7 | -18.1 | -16.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 287 | -106 | -4.87 | -30.1 | -16.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.05 | 3.18 | -55.7 | -9.51 | 0.95 |